The hereditary thrombophilia is an inborn inclination to an increased blood sedimentation. This, however, gives the carrier an advantage of a faster bleeding arrest in case of an injury or in a childbirth, but in some situations – for example in pregnancy or in a long term immobilization – the thrombophilic patients have an increased risk of thrombo-embolic disease (TEN). Blood clots are created in their vessels, which can result in a reduction in blood flow to vital organs (e.g. lungs).
Genes of the hereditary thrombophilia are transferred to the offsprings in combinations of various severity, according to the genetic equipment of the parents. So far the most significant known gene causing thrombophilia is the so-called „Leiden mutation“ (FVL), which is received – in most cases from one parent only – by about every twentieth inhabitant of the Czech Republic.
One of the other risk factors of TEN is an accumulation of the amino acid homocysteine in blood, often related to the hereditary deceleration of metabolism of the folic acid (alteration of the gene MTHFR). In case of a long term decrease in the supply of the folic acid and vitamins of the B group, homocysteine damages the cells of the vessel epithelium and makes the formation of blood clots easier.
Measures in case of the hereditary thrombophilia diagnosis:
19.04.2012New GENNET clinic in LondonWe are delighted to announce the opening of our London unit for fertility, gynaecology and ...
02.04.2012We update our price list according to exchange rate annually on April 1st of each ...